Tenon Medical (TNON) CEO details RSU conversion and tax-liability share sale
Rhea-AI Filing Summary
Tenon Medical, Inc. reported equity compensation activity by CEO and President Steven M. Foster140,936 Restricted Stock Units (RSUs) that were granted on October 13, 2025 converted into 140,936 shares of common stock, with each RSU representing a contingent right to one share.
In a related transaction on August 3, 2026, 41,788 shares of common stock were disposed of at $0.198 per share. Footnote disclosure states these shares were sold to pay the tax liability associated with the vesting of the RSUs, indicating a tax-withholding disposition rather than an open-market portfolio trade.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 99,148 shares
Net Buy
3 txns
Insider
FOSTER STEVEN M
Role
CEO and President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock F2 | 41,788 | $0.198 | $8K |
| Exercise | Restricted Stock Units F1, F3 | 140,936 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 140,936 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock — 262,962 shares (Direct)
Footnotes (3)
- F1. Represents conversion of 140,936 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 140,936 shares of common stock of the Issuer on July 31, 2026.
- F2. These shares were sold to pay tax liability associated with the vesting of RSUs.
- F3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Key Figures
RSUs converted: 140,936 units
Shares received from RSU conversion: 140,936 shares
Shares sold for tax liability: 41,788 shares
+1 more
4 metrics
RSUs converted
140,936 units
Restricted Stock Units converted into common stock on July 31, 2026
Shares received from RSU conversion
140,936 shares
Common stock issued upon RSU conversion on July 31, 2026
Shares sold for tax liability
41,788 shares
Common stock disposed of on August 3, 2026 to pay RSU-related taxes
Tax-liability sale price
$0.1980 per share
Price for 41,788 shares sold to cover tax liability on August 3, 2026
Key Terms
Restricted Stock Units, contingent right, tax liability, derivative security
4 terms
Restricted Stock Units financial
"Represents conversion of 140,936 restricted stock units ('RSUs') granted to the reporting person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of common stock"
tax liability financial
"These shares were sold to pay tax liability associated with the vesting of RSUs"
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider activity did Tenon Medical (TNON) report for CEO Steven M. Foster?
Tenon Medical reported that CEO Steven M. Foster had 140,936 RSUs convert into 140,936 shares of common stock on July 31, 2026, and later 41,788 shares were sold at $0.198 per share to cover RSU-related tax liabilities.
How many Restricted Stock Units vested for Tenon Medical (TNON) CEO and when were they granted?
The CEO had 140,936 RSUs convert into common shares. Footnotes state these RSUs were granted on October 13, 2025 and converted into 140,936 shares of common stock on July 31, 2026 as part of his equity compensation.
What does the RSU conversion mean for Tenon Medical (TNON) CEO’s equity compensation?
The conversion means 140,936 Restricted Stock Units, each a contingent right to one share, became 140,936 shares of common stock. This reflects the vesting and settlement of a previously granted equity award to the CEO.
Were Tenon Medical (TNON) CEO transactions reported as option exercises or RSU conversions?
The transactions reflect a conversion of Restricted Stock Units rather than traditional stock options. 140,936 RSUs converted into the same number of common shares, followed by a tax-related share sale of 41,788 shares to cover obligations from that vesting.